Novartis AG DSO Ratio 2011-2026 | NVS

Annual DSO Ratio Novartis AG

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	0.045	0.0412	-	75.3	76.4	69.8	78.3	79.5	76.1

All numbers in USD currency

Maximum	Minimum	Average
79.5	0.0412	56.9

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	271	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aptorum Group Limited APM	20.6	$ 0.84	2.78 %	$ 4.58 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Adagene ADAG	53.8	$ 2.95	10.3 %	$ 166 M	China
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Amarin Corporation plc AMRN	157	$ 15.08	2.24 %	$ 6.15 B	Irlanda
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.51	-1.68 %	$ 8.45 B	Australia
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
Ascendis Pharma A/S ASND	132	$ 222.25	0.1 %	$ 5 B	Danmark
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Athersys ATHX	22.6	-	3.77 %	$ 22.4 M	USA
Baudax Bio BXRX	126	-	0.59 %	$ 63 K	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 4.4	2.8 %	$ 9.57 B	Israel
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Amneal Pharmaceuticals AMRX	55.7	$ 14.79	1.83 %	$ 4.57 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA